Acupuncture for Postoperative Gastric Emptying Delay
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorQilu Hospital of Shandong University
About this trial
This multicenter clinical trial, conducted at Qilu Hospital of Shandong University and collaborating institutions, prospectively assesses the efficacy and safety of acupuncture for postoperative delayed gastric emptying. Eligible participants will be prospectively enrolled and randomized into different groups per the study protocol. The primary endpoint is the reduction in the duration of delayed gastric emptying, while secondary endpoints include the complete resolution of cardinal gastroparetic symptoms, such as abdominal distension, nausea, and vomiting. All study procedures adhere to the ethical standards outlined in the approved protocol.
Eligibility criteria
Qualifiers
Aged 18-80 years, regardless of sex.
Patients who have undergone partial gastrectomy.
Patients presenting with postoperative gastroparesis symptoms, confirmed by imaging or gastric emptying scintigraphy, and clinically diagnosed with gastroparesis.
No severe cardiac, hepatic, renal, or coagulation dysfunction.
Disqualifiers
Patients with severe cardiovascular or cerebrovascular diseases, hepatic or renal failure, or coagulation disorders.
Patients who develop serious postoperative complications after partial gastrectomy, such as anastomotic leakage, gastrointestinal bleeding, or severe infections, or conditions that may affect the assessment of gastric motility, such as ascites or intestinal obstruction.
Patients with a known allergy to acupuncture or with skin damage, infection, or severe scarring at the needle insertion sites that would prevent proper acupoint selection or needling.
Patients with diagnosed psychiatric disorders, cognitive impairment, or those unable to cooperate with treatment procedures, symptom assessment, or follow-up.
Trial design
Treatments tested in this trial
- Acupuncture
- sham acupuncture
Treatment groups
176 Participants
are divided into 2 treatment groupsSponsors and collaborators
Qilu Hospital of Shandong University
Lead sponsor
Weifang Yidu Central Hospital
Collaborator
The People's Hospital of Yinan County
Collaborator
Source ClinicalTrials.gov